These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34918250)

  • 1. Glucan Particles: Choosing the Appropriate Size to Use as a Vaccine Adjuvant.
    Colaço M; Panão Costa J; Borges O
    Methods Mol Biol; 2022; 2412():269-280. PubMed ID: 34918250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the immunomodulatory properties of glucan particles in human primary cells.
    Jesus S; Panão Costa J; Colaço M; Lebre F; Mateus D; Sebastião AI; Cruz MT; Alfaro-Moreno E; Borges O
    Int J Pharm; 2024 Apr; 655():123996. PubMed ID: 38490404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.
    Soares E; Groothuismink ZMA; Boonstra A; Borges O
    Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Glucan Particles as Vaccine Adjuvant Carriers.
    Mirza Z; Soto ER; Dikengil F; Levitz SM; Ostroff GR
    Methods Mol Biol; 2017; 1625():143-157. PubMed ID: 28584989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen.
    Soares E; Jesus S; Borges O
    Eur J Pharm Biopharm; 2018 Oct; 131():33-43. PubMed ID: 30048745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial exopolysaccharides-β-glucans-as promising postbiotic candidates in vaccine adjuvants.
    Abbasi A; Rahbar Saadat T; Rahbar Saadat Y
    Int J Biol Macromol; 2022 Dec; 223(Pt A):346-361. PubMed ID: 36347372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duality of β-glucan microparticles: antigen carrier and immunostimulants.
    Baert K; De Geest BG; De Greve H; Cox E; Devriendt B
    Int J Nanomedicine; 2016; 11():2463-9. PubMed ID: 27330289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
    Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan.
    Fredriksen BN; Sævareid K; McAuley L; Lane ME; Bøgwald J; Dalmo RA
    Vaccine; 2011 Oct; 29(46):8338-49. PubMed ID: 21888940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives.
    Patil V; Hernandez-Franco JF; HogenEsch H; Renukaradhya GJ
    Front Immunol; 2022; 13():858321. PubMed ID: 36119085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-glucans as potential immunoadjuvants: A review on the adjuvanticity, structure-activity relationship and receptor recognition properties.
    Jin Y; Li P; Wang F
    Vaccine; 2018 Aug; 36(35):5235-5244. PubMed ID: 30049632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-glucan as a new tool in vaccine development.
    Vetvicka V; Vannucci L; Sima P
    Scand J Immunol; 2020 Feb; 91(2):e12833. PubMed ID: 31544248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum hydroxide colloid vaccine encapsulated in yeast shells with enhanced humoral and cellular immune responses.
    Liu H; Jia Z; Yang C; Song M; Jing Z; Zhao Y; Wu Z; Zhao L; Wei D; Yin Z; Hong Z
    Biomaterials; 2018 Jun; 167():32-43. PubMed ID: 29554479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate-containing nanoparticles as vaccine adjuvants.
    Zhang X; Zhang Z; Xia N; Zhao Q
    Expert Rev Vaccines; 2021 Jul; 20(7):797-810. PubMed ID: 34101528
    [No Abstract]   [Full Text] [Related]  

  • 16. Yeast Shells Encapsulating Adjuvant AS04 as an Antigen Delivery System for a Novel Vaccine against
    Zhu L; Lei Z; Xia X; Zhang Y; Chen Y; Wang B; Li J; Li G; Yang G; Cao G; Yin Z
    ACS Appl Mater Interfaces; 2021 Sep; 13(34):40415-40428. PubMed ID: 34470103
    [No Abstract]   [Full Text] [Related]  

  • 17. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants.
    Lu F; Mencia A; Bi L; Taylor A; Yao Y; HogenEsch H
    J Control Release; 2015 Apr; 204():51-9. PubMed ID: 25747143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of particulate and soluble (1-3)-beta-glucans on Ca2+ influx in NR8383 alveolar macrophages.
    Mörk AC; Helmke RJ; Martinez JR; Michalek MT; Patchen ML; Zhang GH
    Immunopharmacology; 1998 Jul; 40(1):77-89. PubMed ID: 9776481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of guinea pigs against Entamoeba histolytica using glucan as an adjuvant.
    Sharma A; Haq AU; Siddiqui MU; Ahmad S
    Int J Immunopharmacol; 1984; 6(5):483-91. PubMed ID: 6094370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.
    Jia J; Zhang W; Liu Q; Yang T; Wang L; Ma G
    Mol Pharm; 2017 Jan; 14(1):14-22. PubMed ID: 28043126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.